IMRX vs INAB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 24, 2026

IMRX

38.7
AI Score
VS
IMRX Wins

INAB

32.9
AI Score

Investment Advisor Scores

IMRX

39score
Recommendation
SELL

INAB

33score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric IMRX INAB Winner
Net Income -53.47M -9.87M INAB
Operating Income -58.41M -9.87M INAB
ROE -59.0% -53.8% INAB
ROA -52.1% -45.4% INAB
Total Assets 102.58M 21.75M IMRX
Cash 59.41M 17.96M IMRX
Current Ratio 11.35 8.21 IMRX

Relative Price Performance (Last 90 Days)

IMRX 1M: +20.7% · 3M: +1.5% INAB 1M: +7.6% · 3M: -23.8%

Current Technical Phase

IMRX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 63

RSI (14): 62.7 · Price: $5.30

INAB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 60

RSI (14): 60.2 · Price: $1.28

Fundamentals Snapshot

Metric IMRX INAB
Market Cap
Forward P/E -4.2 -1.3
Trailing P/E
Revenue (TTM)
Revenue Growth -1.0% 0.0%
Gross Margin 349.1%
Operating Margin 0.0% 0.0%
EPS -0.92 -1.30
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, IMRX is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.